Akanocure Pharmaceuticals Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 6

Akanocure Pharmaceuticals General Information

Description

Developer of anti-cancer chemotherapeutic drugs designed to treat various forms of cancer. The company's drugs focus on the synthesis and development of bio-targeted anti-cancer chemotherapeutics derived from natural resources, enabling doctors to treat side effects of chemotherapy and cancer treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Purdue Research Park, Ross Enterprise Center
  • 3495 Kent Avenue, Suite E-100
  • West Lafayette, IN 47906
  • United States
+1 (765) 000-0000

Akanocure Pharmaceuticals Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akanocure Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Apr-2021 00000 Completed Generating Revenue
6. Grant 29-Apr-2020 00000 00000 Completed Generating Revenue
5. Grant 24-Jan-2018 00000 00000 Completed Generating Revenue
4. Early Stage VC 15-Aug-2017 00000 Completed Generating Revenue
3. Accelerator/Incubator 23-May-2017 00000 Completed Generating Revenue
2. Accelerator/Incubator 05-Jun-2015 $100K $120K Completed Generating Revenue
1. Angel (individual) 20-Jan-2015 $20K $20K Completed Generating Revenue
To view Akanocure Pharmaceuticals’s complete valuation and funding history, request access »

Akanocure Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of anti-cancer chemotherapeutic drugs designed to treat various forms of cancer. The company's drugs focus on
Drug Discovery
West Lafayette, IN
3 As of 2017
00000
000000000000 00000

00000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000000
Boston, MA
00 As of 0000
000.00
0000000000 0 000.00

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akanocure Pharmaceuticals Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardurion Pharma Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000 000000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000 00000
0000 000000000000 Corporation Bedminster, NJ 00 0000 000000000 0000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
To view Akanocure Pharmaceuticals’s complete competitors history, request access »

Akanocure Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Sherine Abdelmawla Ph.D Co-Founder, Board Member & Chief Executive Officer
Mohammad Noshi Ph.D Co-Founder, Board Member, President of R&D & Chief Operating Officer
Philip Fuchs Ph.D Co-Founder, Board Member & CSO
Wael Harb Advisor
Allen Ritter Ph.D Advisor
To view Akanocure Pharmaceuticals’s complete executive team members history, request access »

Akanocure Pharmaceuticals Board Members (4)

Name Representing Role Since
Chris Seybold Founder.org Board Member 000 0000
John Bamforth Ph.D Self Board Member & Chairman 000 0000
Mohammad Noshi Ph.D Akanocure Pharmaceuticals Co-Founder, Board Member, President of R&D & Chief Operating Officer 000 0000
Sherine Abdelmawla Ph.D Akanocure Pharmaceuticals Co-Founder, Board Member & Chief Executive Officer 000 0000
To view Akanocure Pharmaceuticals’s complete board members history, request access »

Akanocure Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akanocure Pharmaceuticals Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Purdue Ventures Venture Capital Minority 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
Founder.org Accelerator/Incubator Minority 000 0000 000000 0
Purdue Research Foundation Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »